The association of sleep disturbances with glycemia and obesity in youth at risk for or with recently diagnosed type 2 diabetes
- PMID: 31486162
- PMCID: PMC7199716
- DOI: 10.1111/pedi.12917
The association of sleep disturbances with glycemia and obesity in youth at risk for or with recently diagnosed type 2 diabetes
Abstract
Objective: Poor sleep may increase obesity and type 2 diabetes (T2D) risk in youth. We explored whether subjective sleep duration, sleep quality, or risk for obstructive sleep apnea (OSA) are associated with glycemia, body mass index (BMI), or blood pressure (BP) in overweight/obese youth.
Methods: Two-hundred and fourteen overweight/obese youth of 10 to 19 years of age at risk for or recently diagnosed with T2D who were screened for the Restoring Insulin Secretion (RISE) Study had a 2-hour oral glucose tolerance test (OGTT) and completed a Cleveland Adolescent Sleepiness questionnaire and a Sleep Disturbances Scale questionnaire. Independent associations between sleep variables and measures of glycemia, BMI, and BP were evaluated with regression models.
Results: The multiethnic cohort was 67% female, 14.1 ± 2.1 years, and BMI 35.9 ± 6.5 kg/m2 . Habitual sleep duration <8 hours was reported in 74%. Daytime sleepiness was reported in 51%, poor sleep quality in 26%, and 30% had high obstructive sleep apnea (OSA) risk. Daytime sleepiness was associated with higher HbA1c (0.2%, P = .02) and 2-hour glucose (13.6 mg/dL, P < .05). Sleep duration, sleep quality, and OSA risk were not associated with the evaluated outcomes. Poor sleep quality and OSA risk were associated with higher BMI (2.9 kg/m2 , P = .004 and 2.83 kg/m2 , P < .003, respectively).
Conclusions: In overweight/obese youth with or at risk for T2D, daytime sleepiness was associated with higher HbA1c. In addition, poor sleep quality and OSA risk were associated with higher BMI. These findings support intervention studies aimed at improving sleep quality in obese youth.
Keywords: adolescents; children; glucose; glycemia; hemoglobin A1c; hypersomnolence; hypertension; obesity; sleep apnea; sleep duration; sleep quality; sleepiness.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
CONFLICTS OF INTEREST
The authors declare no potential conflict of interest.
Figures

Similar articles
-
Association of Self-Reported Sleep and Circadian Measures With Glycemia in Adults With Prediabetes or Recently Diagnosed Untreated Type 2 Diabetes.Diabetes Care. 2019 Jul;42(7):1326-1332. doi: 10.2337/dc19-0298. Epub 2019 May 2. Diabetes Care. 2019. PMID: 31048411 Free PMC article.
-
Obstructive Sleep Apnea, Glucose Tolerance, and β-Cell Function in Adults With Prediabetes or Untreated Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study.Diabetes Care. 2021 Apr;44(4):993-1001. doi: 10.2337/dc20-2127. Epub 2021 Feb 5. Diabetes Care. 2021. PMID: 33547205 Free PMC article.
-
Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.J Endocrinol Invest. 2018 Aug;41(8):969-975. doi: 10.1007/s40618-017-0823-7. Epub 2018 Jan 5. J Endocrinol Invest. 2018. PMID: 29305826
-
Sleep apnea is a manifestation of the metabolic syndrome.Sleep Med Rev. 2005 Jun;9(3):211-24. doi: 10.1016/j.smrv.2005.01.006. Sleep Med Rev. 2005. PMID: 15893251 Review.
-
Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea--a review.Sleep. 2012 May 1;35(5):605-15. doi: 10.5665/sleep.1812. Sleep. 2012. PMID: 22547886 Free PMC article. Review.
Cited by
-
Unraveling the associations and causalities between glucose metabolism and multiple sleep traits.Front Endocrinol (Lausanne). 2023 Nov 7;14:1227372. doi: 10.3389/fendo.2023.1227372. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027156 Free PMC article.
-
Associations of Obstructive Sleep Apnea Risk with Obesity, Body Composition and Metabolic Abnormalities in School-Aged Children and Adolescents.Nutrients. 2024 Jul 25;16(15):2419. doi: 10.3390/nu16152419. Nutrients. 2024. PMID: 39125300 Free PMC article.
-
Youth-onset type 2 diabetes mellitus: an urgent challenge.Nat Rev Nephrol. 2023 Mar;19(3):168-184. doi: 10.1038/s41581-022-00645-1. Epub 2022 Oct 31. Nat Rev Nephrol. 2023. PMID: 36316388 Free PMC article. Review.
-
Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation.Front Pharmacol. 2022 Aug 30;13:990996. doi: 10.3389/fphar.2022.990996. eCollection 2022. Front Pharmacol. 2022. PMID: 36110515 Free PMC article.
-
A pragmatic trial of a family-centered approach to childhood obesity treatment: Rationale and study design.Contemp Clin Trials. 2024 Mar;138:107459. doi: 10.1016/j.cct.2024.107459. Epub 2024 Jan 24. Contemp Clin Trials. 2024. PMID: 38278478 Free PMC article. Clinical Trial.
References
-
- Matricciani L, Olds T, Petkov J. In search of lost sleep: secular trends in the sleep time of school-aged children and adolescents. Sleep Med Rev. 2012;16:203–211. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK094406/DK/NIDDK NIH HHS/United States
- U01-DK-094438/DK/NIDDK NIH HHS/United States
- UL1 TR001857/TR/NCATS NIH HHS/United States
- UL1-TR-001108/NH/NIH HHS/United States
- U01 DK094430/DK/NIDDK NIH HHS/United States
- UL1-TR-000430/NH/NIH HHS/United States
- UL1-TR-001863/NH/NIH HHS/United States
- P30-DK-045735/DK/NIDDK NIH HHS/United States
- P30 DK045735/DK/NIDDK NIH HHS/United States
- UL1-TR-001857/NH/NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- P30 DK092949/DK/NIDDK NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
- UL1 TR000430/TR/NCATS NIH HHS/United States
- P30-DK-017047/DK/NIDDK NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- U01-DK-094430/DK/NIDDK NIH HHS/United States
- UL1-TR-001855/NH/NIH HHS/United States
- U01 DK094431/DK/NIDDK NIH HHS/United States
- VA/VA/United States
- R01HL119161/HL/NHLBI NIH HHS/United States
- TL1 TR001858/TR/NCATS NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- U01 DK094438/DK/NIDDK NIH HHS/United States
- P30-DK-020595/DK/NIDDK NIH HHS/United States
- U01-DK-094406/DK/NIDDK NIH HHS/United States
- U01 DK094467/DK/NIDDK NIH HHS/United States
- P30 DK097512/DK/NIDDK NIH HHS/United States
- T32 HL007909/HL/NHLBI NIH HHS/United States
- R01 HL119161/HL/NHLBI NIH HHS/United States
- K24 HL145076/HL/NHLBI NIH HHS/United States
- UL1-TR-001082/NH/NIH HHS/United States
- UL1 TR001855/TR/NCATS NIH HHS/United States
- UL1-TR-001858/NH/NIH HHS/United States
- P30-DK-097512/DK/NIDDK NIH HHS/United States
- U01-DK-094431/DK/NIDDK NIH HHS/United States
- U01-DK-094467/DK/NIDDK NIH HHS/United States
- P30 DK020595/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical